Health food store recommendations could be bad for your health

August 06, 2003

Patients with breast cancer may be put at risk if they follow misleading advice from health food store employees. Research published this week in Breast Cancer Research shows that store assistants often recommend products with no proven benefit, that are also expensive and potentially harmful.

Edward Mills from the Canadian College of Naturopathic Medicine carried out the research with colleagues from University of Toronto and University of Exeter. The aim was to find out what advice health food store employees give people who seek alternative treatment options for breast cancer. The researchers found that, "health food stores are recommending a variety of products, [...] none of which are supported by sufficient evidence of efficacy ".

The average cost of these products was $58 per month, with the more expensive remedies of up to $600 relying on "insufficient or questionable research". In addition, many recommendations were unaccompanied by discussions on the possible adverse effects of the product, or its potential interaction with conventional cancer treatments.

To collect the data, eight people, who had been trained to act as customers whose mothers' were suffering from breast cancer, visited 34 Canadian stores. They browsed the store until approached by an employee and then asked for product recommendations, giving information about their mothers' treatment regime only when asked. They then followed a memorised questionnaire to get information about the costs involved, the usage, effectiveness and safety of the product offered and the relevant education of the employee.

33 different products were recommended, none of which was supported by evidence of effectiveness. 23 employees (68%) did not ask whether the patient was taking prescribed medication. Only three employees (8.8%) discussed the adverse effects of the products and only eight employees (23.5%) pointed out that the products might interact with prescribed drugs. Two employees suggested that the products may cure the breast cancer, and one counselled to cease conventional treatment with Tamoxifen because it was "poisonous".

Only three of the employees had had any formal education in complementary and alternative medicine. Several said that formal education was unnecessary, and others that working in the health food environment for several years was experience enough.

The authors ask for educational initiatives to be aimed at health store workers to create a safer and more evidence-based health food business. They say that many patients are attracted to natural health products because they consider them natural and therefore less toxic than prescription medicine. Yet, recent reports suggest that these products may interact with drugs used in chemotherapy, by reducing their effectiveness or increasing toxicity. Mills and colleagues urge physicians to be aware that their patients could be taking natural health products and that these may be the source of unexplained reactions to treatment.

Mills and his colleagues believe that action is needed: "Governing bodies should consider health food stores as commonly utilised, yet unregulated, sections of the health care system...Regulators need to consider regulations to better protect vulnerable patients from incurring significant costs due to their purchasing of natural health food products lacking evidence of benefit and of questionable safety."

Mills said, "Patients with breast cancer are in the difficult situation of seeking treatment options and are susceptible to misinformation. It is unfortunate that we do not have better evidence of risks or benefits of natural health products to guide decision making for this vulnerable population".
-end-
This article is freely available online, according to Breast Cancer Research's policy of open access to research articles.

Health Food Store Recommendations: Implications for Breast Cancer Patients
Breast Cancer Research Vol. 5 No. 6
Edward Mills, Edzard Ernst, Rana Singh, Cory Ross and Kumanan Wilson.
http://breast-cancer-research.com/content/pdf/bcr636.pdf
Published 6th August 2003

Please quote the URL in any article, so that your readers can read the original article.

For more information about this article, please contact the author Dr Edward Mills by email at emills@ccnm.edu or by phone on 416-498-1255 ext. 324

Alternatively, contact Gemma Bradley by email at press@biomedcentral.com or by phone on 44-0-20-7323-0323

Breast Cancer Research (http://breast-cancer-research.com/) is published by BioMed Central (http://www.biomedcentral.com), an independent online publishing house committed to providing immediate free access to peer-reviewed biological and medical research. This commitment is based on the view that open access to research is essential to the rapid and efficient communication of science. In addition to open-access original research, BioMed Central also publishes reviews and other subscription-based content.

BioMed Central

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.